Puma Biotechnology
PBYI
PBYI
68 hedge funds and large institutions have $93.8M invested in Puma Biotechnology in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 14 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
12% less funds holding
Funds holding: 77 → 68 (-9)
52% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 29
75% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 12
Holders
68
Holding in Top 10
1
Calls
$1.41M
Puts
$230K
Top Buyers
| 1 | +$405K | |
| 2 | +$262K | |
| 3 | +$180K | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$106K |
| 5 |
PFGIA
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
|
+$102K |
Top Sellers
| 1 | -$1.28M | |
| 2 | -$988K | |
| 3 | -$634K | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$411K |
| 5 |
Two Sigma Investments
New York
|
-$360K |